|
|
|
|
MTM, pharmacy measures in final HCR bill
Cost analysis, text of bill released as clock ticks toward House vote on Sunday.With a nonpartisan cost estimate showing that the final health care reform (HCR) bill will reduce the federal deficit in each of the next two decades, the House of...
|
|
|
[OctoPlus N.V. (NL) - OctoPlus announces publication of positive Locteron interim Phase IIb data
OctoPlus N.V.('OctoPlus' or 'the Company') (Euronext: OCTO) announces publication of an abstract containing preliminary Locteron Phase IIb clinical results. The abstract was submitted by OctoPlus' licensee Biolex and has been accepted for an oral...
|
|
|
Chlamydia tests with pints
CHLAMYDIA testing in Chelmsford is at the forefront of tackling the spread of the sexually transmitted disease.A pub in the town has been offering its support. The Ivory Peg has been supporting the NHSs effort to seek out candidates to screen. On...
|
|
|
Bioluminescent imaging of reporter gene expression in the lungs of wildtype and model mice following the administration of PEG-stabilized DNA nanoparticles
DNA nanoparticles (DNPs) formed by compacting DNA with polyethyleneglycolylated poly-L-lysine are a nonviral vector shown to be safe and efficacious in animals and humans.To extend our capabilities of assessing the efficacy and duration of expression...
|
|
|
Skin cancer has become an 'epidemic' in the U.S., researchers say
LOS ANGELES, Mar.16, 2010 (McClatchy-Tribune News Service delivered by Newstex) -- Non-melanoma skin cancer is the most common type of cancer in the U.S. But just how common is it? According to a new estimate, more than 2.1 million Americans were treated...
|
|
|
Manufacturing news in brief
Developments in the pharmaceutical manufacturing arena in the last week include facility news for Dr Reddy's, Dishman, W.Grace, Haselmeier and Fresenius Kabi, first-quarter results for Patheon and a new contract for Angel Biotech of the UK. UK contract...
|
|
|
ZymoGenetics, Inc. - Pharmaceuticals & Healthcare - Deals And Alliances Profile - New Report Published
Newly released report, ZymoGenetics, Inc.- Pharmaceuticals & Healthcare - Deals and Alliances Profile, provides detailed company analysis Published on March 19, 2010by Press Office(Companiesandmarkets.com and OfficialWire)LONDON, ENGLAND ZymoGenetics,...
|
|
|
Accelerated FDA Approval Legislation Would Bypass 2007 Court Decision Rules Opens Door To Sunday Vote, Sen. Dems To Grant Assurance To House Safety & Health Coalition Pegs OSHA Reform, Ergo, Training As Top Priorities House Passes 1-Month Stopgap For SGR
_ Accelerated FDA Approval Legislation Would Bypass 2007 Court Decision Rules Opens Door To Sunday Vote, Sen.Dems To Grant Assurance To House Safety & Health Coalition Pegs OSHA Reform, Ergo, Training As Top Priorities House Passes 1-Month Stopgap...
|
|
|
Rising rates: Skin cancer an epidemic in U.S., researchers say
Non-melanoma skin cancer is the most common type of cancer in the United States.But just how common is it? According to a new estimate, more than 2.1 million Americans were treated for 3.5 million cases of the cancers in 2006? Since cases of non-melanoma...
|
|
|
Skin cancer has become an epidemic, researchers say
LOS ANGELES Non-melanoma skin cancer is the most common type of cancer in the U.S.But just how common is it? According to a new estimate, more than 2.1 million Americans were treated for 3.5 million cases of the cancers in 2006? Since cases of non...
|
|
|
Skin cancer 'epidemic' in U.S
Non-melanoma skin cancer is the most common type of cancer in the U.S.But just how common is it? According to a new estimate, more than 2.1 million Americans were treated for 3.5 million cases of the cancers in 2006? Since cases of non-melanoma skin...
|
|
|
GlobeImmune Announces Presentations of GI-5005 Phase 2b Data at EASL 2010 Meeting
Sustained Virologic Response, Pharmacogenomic and Biopsy Analysis of HCV Patients Receiving GI-5005 Therapeutic Vaccine to be Presented at the Annual Meeting of the European Association for the Study of the Liver LOUISVILLE, Colo., March 17, 2010 - GlobeImmune...
|
|
|
GlobeImmune Announces Presentations of GI-5005 Phase 2b Data at EASL 2010 Meeting
Sustained Virologic Response, Pharmacogenomic and Biopsy Analysis of HCV Patients Receiving GI-5005 Therapeutic Vaccine to Be Presented at the Annual Meeting of the European Association for the Study of the Liver GlobeImmune Inc.today announced that three...
|
|
|
Dr Reddy's Lab commissions mPEG alcohol manufacturing facility in Mexico
The Custom Pharmaceutical Services (CPS) business of Dr Reddy's Laboratories Ltd has successful commissioned its commercial scale manufacturing facility for pharma grade m PEG alcohols at its Cuernavaca facility in Mexico.mPEG alcohols are the key raw...
|
|
|
BioMarin to Present at the Barclays Capital Global Healthcare Conference
NOVATO, Calif., March 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.(Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare...
|
|
|
Learning Styles in Doubt
New report claims 'auditory', 'visual' learning designations invalid.View Comments (0)Print Articl Facebookreddit Newsvine Del.icio.us Digg Yahoo! BuzzLinkedIn StumbleUpon Google Bookmarks Mixx Are you a verbal learner or a visual learner! Chances are...
|
|
|
Reform package cost pegged at $940 billion
_ Reform package cost pegged at $940 billion.
|
|
|
Reform package cost pegged at $940 billion
_ Reform package cost pegged at $940 billion.
|
|
|
Reform package cost pegged at $940 billion
_ Reform package cost pegged at $940 billion.
|
|
|
News: Pores off the peg
_ News: Pores off the peg.
|
|
|
GlobeImmune Announces Presentations of GI-5005 Phase 2b Data at EASL 2010 Meeting
GlobeImmune Inc.today announced that three abstracts related to GI-5005, the company's hepatitis C (HCV) product candidate, have been accepted for presentation at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL) to be...
|
|
|
GlobeImmune Announces Presentations of GI-5005 Phase 2b Data at EASL 2010 Meeting
Companies mentioned in this article: GlobeImmune, Inc.LOUISVILLE, CO -- (Marketwire) -- 03/17/10 -- GlobeImmune Inc. today announced that three abstracts related to GI-5005, the company's hepatitis C (HCV) product candidate, have been accepted for...
|
|
|
BioMarin to Present at the Barclays Capital Global Healthcare Conference
NOVATO, Calif., March 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.(Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare...
|
|
|
BioMarin to Present at the Barclays Capital Global Healthcare Conference
NOVATO, Calif., March 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.(Nasdaq: BMRN) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare...
|
|
|
BioMarin to Present at the Barclays Capital Global Healthcare
BioMarin Pharmaceutical Inc.today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare Conference in Miami on Wednesday, March 24, 2010 at 9:30 a.m.
|
